This information is for the 2019/20 session.
Teacher responsible
Dr Panagiotis Kanavos COW.G.04
Availability
This course is available on the MSc in Health Economics, Policy and Management. This course is not available as an outside option.
Course content
The aim of this course it to introduce students to the economics of pharmaceutical markets and related policies that affect national and international markets broadly.
Teaching
The course will comprise 10 x 1-hour interactive lectures, 1 x 1-hour revision session and 5 x 2-hour interactive seminars, where students will discuss specific case studies.
Formative coursework
Up to 1500 word formative essay, to mirror an exam question, to be written during seminar time.
Indicative reading
E Mossialos, M Mrazek & T Walley (eds), Regulating Pharmaceuticals in Europe. Striving for Efficiency, Equity and Quality, Buckingham, Open University Press (2004); S O Schweitzer, Pharmaceutical Economics and Policy, Oxford University Press (2006); W S Comanor, 'The Political Economy of the Pharmaceutical Industry', Journal of Economic Literature, XXIV (September): 1178-1217 (1986); F M Scherer 'The Pharmaceutical Industry', Chapter 25, in: A J Culyer & J P Newhouse (Eds), Handbook of Health Economics, Vol 1, Amsterdam, Oxford, Elsevier, 2000.
Students will be given access to essential readings before the course begins through the pre-sessional reading programme on Moodle, which they will be expected to read prior to the first day of class.
Assessment
Take home exam (100%) in the LT.
Change of assessment time from ST to LT, teaching for this course takes place in December, the assessment will be scheduled to be completed prior to Easter break to allow executive students to have time to prepare for the next teaching block in ST and not carry over earlier assessment as well.
Key facts
Department: Health Policy
Total students 2018/19: Unavailable
Average class size 2018/19: Unavailable
Controlled access 2018/19: No
Value: Half Unit